ArticleScientific reports2025
Screening of rhizobacteria from monkey pod trees for plant growth promoters and evaluating the antifungal potential of the biosynthesized selenium nanoparticles.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antifungal Efficacy of Selenium Microparticles Biosynthesized byFoods (Basel, Switzerland) · 2026Article
- Soil selenium activator mediates selenium form transformation and affects soil properties and microbial communities.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhizobacteria, residing in the root zone of plants, are essential for enhancing plant growth and development and have recently been recognized for their role in nanoparticle synthesis. This study aims to isolate new strains of rhizobacteria from monkey pod trees, evaluate their potential as plant growth promoters, and assess their ability to synthesize selenium nanoparticles (SeNPs) with antifungal properties. The objectives include screening the isolates for phosphate solubilization potential, indolic compound production, nitrogen fixation, and SeNPs synthesis. The best-performing isolates were identified through molecular techniques, and the synthesized SeNPs were characterized and tested for antifungal activity. Out of 30 rhizobacterial strains screened, isolates RS3E and RS3F, identified as Lysinibacillus sphaericus and Bacillus amyloliquefaciens, respectively, showed significant phosphate solubilization (PSI ranging from 2.0 to 3.80 mm) and Indole Acetic Acid (IAA) production. The greenly synthesized SeNPs exhibited a maximum absorption at 262 nm, with scanning and transmission electron microscopy confirming their spherical nature and average particle size of 16.704 nm. Further validation of SeNPs synthesis was achieved using Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), and energy dispersive X-ray (EDX) analysis. The SeNPs demonstrated excellent antifungal activity against Aspergillus niger and Aspergillus flavus, with inhibition zones ranging from 23.0 to 45.0 mm. This study highlights the potential of rhizobacteria-derived SeNPs as effective antifungal agents, offering a sustainable approach to fungal treatment in agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.